Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma

Molecular Medicine Reports

Volumn 7, Issue 3, 2013, Pages 1055-1061

  Peng, Ling ^a   Yang, Zesong ^a   Tan, Cui ^a   Ren, Guosheng ^a   Chen, Jianbin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

ADAMTS9; Epigenetic; KM3; Multiple myeloma; Promoter methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ADAMTS9 PROTEIN; METALLOPROTEINASE; TRICHOSTATIN A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW BIOPSY; CANCER PATIENT; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETIC REPRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE INACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE MYELOMA; MYELOMA CELL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAM PROTEINS; ADULT; AGED; AZACITIDINE; CELL LINE, TUMOR; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; FEMALE; HUMANS; HYDROXAMIC ACIDS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; S PHASE CELL CYCLE CHECKPOINTS;

EID: 84873116499     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1291     Document Type: Article

References (27)

1. Hatzimichael E, Dasoula A, Benetatos L, et al: Study of specific genetic and epigenetic variables in multiple myeloma. Leuk Lymphoma 51:2270-2274, 2010.
2. Rajumar SV and Greipp PR: Prognostic factors in multiple myeloma. Hematol Oncol Clin North Am 13:1295-1314, 1999. (Pubitemid 30017402)
3. Kyle RA and Rajkumar SV: Multiple myeloma. N Engl J Med 351:1860-1873, 2004.
4. Klein U, Jauch A, Hielscher T, et al: Chromosomal aberrations +1q21 and del (17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone. Cancer 117:2136-2144, 2011.
5. Esteller M: Epigenetics in cancer. N Engl J Med 358:1148-1159, 2008.
6. Jost E, Gezer D, Wilop S, et al: Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma. Cancer Lett 281:24-31, 2009.
7. Boultwood J and Wainscoat JS: Gene silencing by DNA methylation in haematological malignancies. Br J Haematol 138:3-11, 2007. (Pubitemid 46889779)
8. Yuregir OO, Yurtcu E, Kizilkilic E, Kocer NE, Ozdogu H and Sahin FI: Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients. Int J Lab Hematol 32:142-149, 2010.
9. Braggio E, Maiolino A, Gouveia ME, et al: Methylation status of nine tumor suppressor genes in multiple myeloma. Int J Hematol 91:87-96, 2010.
10. Ullmannova-Benson V, Guan M, Zhou X, et al: DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway. Leukemia 23:383-390, 2009.
11. Galm O, Yoshikawa H, Esteller M, Osieka R and Herman JG: SOCS.1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 101:2784-2788, 2003. (Pubitemid 36857644)
12. Levy GG, Nichols WC, Lian EC, et al: Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488-494, 2001. (Pubitemid 32938741)
13. Lo PH, Lung H, Cheung AK, et al: Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer Res 70:5567-5576, 2010.
14. Lung HL, Lo PH, Xie D, et al: Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9 and its association with lymph node metastases in nasopharyngeal carcinoma. Int J Cancer 123:401-408, 2008. (Pubitemid 351842026)
15. Zhang C, Shao Y, Zhang W, et al: High-resolution melting analysis of ADAMTS9 methylation levels in gastric, colorectal and pancreatic cancers. Cancer Gene Cytogenet 196:38-44, 2010.
16. Kuo HK, Griffith JD and Kreuzer KN: 5. Azacytidine induced methyltransferase. DNA adducts block DNA replication in vivo. Cancer Res 17:8248-8254, 2007. (Pubitemid 47395162)
17. Sidransky D: Emerging molecular markers of cancer. Nat Rev Cancer 2:210-219, 2002. (Pubitemid 37328790)
18. de Carvalho F, Colleoni GW, Almeida MS, Carvalho AL and Vettore AL: TGFαR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma. Int J Cancer 125:1985-1991, 2009.
19. Lo PH, Leung AC, Kwok CY, et al: Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene 26:148-157, 2007. (Pubitemid 46067340)
20. Li Z, Zhang W, Shao Y, et al: High-resolution melting analysis of ADAMTS18 methylation levels in gastric, colorectal and pancreatic cancers. Med Oncol 27:998-1004, 2010.
21. Moncada-Pazos A, Obaya AJ, Fraga MF, et al: The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci 122:2906-2913, 2009.
22. Viloria CG, Obaya AJ, Moncada-Pazos A, et al: Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer. Cancer Res 69:4926-4934, 2009.
23. Dunn JR, Panutsopulo D, Shaw MW, et al: METH.2 silencing and promoter hypermethylation in NSCLC. Br J Cancer 91:1149-1154, 2004. (Pubitemid 39336255)
24. Dubail J, Kesteloot F, Deroanne C, et al: ADAMTS.2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity. Cell Mol Life Sci 67:4213-4232, 2010.
25. EI Hour M, Moncada-Pazos A, Blacher S, et al: Higher sensitivity of Adamts12.deficient mice to tumor growth and angiogenesis. Oncogene 29:3025-3032, 2010.
26. Dunn JR, Reed JE, du Plessis DG, et al: Expression of ADAMTS.8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours. Br J Cancer 94:1186-1193, 2006.
27. Koo BH, Coe DM, Dixon LJ, et al: ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells. Am J Pathol 176:1494-1504, 2010.